- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 8 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.1: 19 residues within 4Å:- Chain A: S.151, S.152, R.153, R.155, H.214, L.216, W.251, R.259, M.263, R.315, G.317, V.318, H.319, R.343, G.346, G.347, V.348, D.358
- Ligands: MG.2
15 PLIP interactions:15 interactions with chain A- Hydrogen bonds: A:R.153, A:R.315, A:V.318, A:H.319, A:G.346, A:V.348
- Salt bridges: A:R.153, A:R.153, A:R.155, A:R.315, A:R.315, A:R.343, A:R.343
- pi-Cation interactions: A:R.153, A:H.319
ADP.3: 19 residues within 4Å:- Chain B: S.151, S.152, R.153, R.155, H.214, L.216, W.251, R.259, M.263, R.315, G.317, V.318, H.319, R.343, G.346, G.347, V.348, D.358
- Ligands: MG.4
14 PLIP interactions:14 interactions with chain B- Hydrogen bonds: B:R.153, B:R.315, B:G.346, B:V.348, B:D.358
- Salt bridges: B:R.153, B:R.153, B:R.155, B:R.315, B:R.315, B:R.343, B:R.343
- pi-Cation interactions: B:R.153, B:H.319
ADP.5: 18 residues within 4Å:- Chain C: S.151, S.152, R.153, R.155, H.214, L.216, W.251, R.259, M.263, R.315, G.317, V.318, H.319, R.343, G.346, G.347, V.348
- Ligands: MG.6
14 PLIP interactions:14 interactions with chain C- Hydrogen bonds: C:R.153, C:R.315, C:G.317, C:G.346, C:V.348
- Salt bridges: C:R.153, C:R.153, C:R.155, C:R.315, C:R.315, C:R.343, C:R.343
- pi-Cation interactions: C:R.153, C:H.319
ADP.7: 19 residues within 4Å:- Chain D: S.151, S.152, R.153, R.155, H.214, L.216, W.251, R.259, M.263, R.315, G.317, V.318, H.319, R.343, G.346, G.347, V.348, D.358
- Ligands: MG.8
16 PLIP interactions:16 interactions with chain D- Hydrogen bonds: D:R.153, D:R.259, D:R.315, D:G.317, D:H.319, D:G.346, D:V.348
- Salt bridges: D:R.153, D:R.153, D:R.155, D:R.315, D:R.315, D:R.343, D:R.343
- pi-Cation interactions: D:R.153, D:H.319
ADP.9: 19 residues within 4Å:- Chain E: S.151, S.152, R.153, R.155, H.214, L.216, W.251, R.259, M.263, R.315, G.317, V.318, H.319, R.343, G.346, G.347, V.348, D.358
- Ligands: MG.10
16 PLIP interactions:16 interactions with chain E- Hydrogen bonds: E:R.153, E:R.259, E:R.315, E:G.317, E:H.319, E:G.346, E:V.348
- Salt bridges: E:R.153, E:R.153, E:R.155, E:R.315, E:R.315, E:R.343, E:R.343
- pi-Cation interactions: E:R.153, E:H.319
ADP.11: 19 residues within 4Å:- Chain F: S.151, S.152, R.153, R.155, H.214, L.216, W.251, R.259, M.263, R.315, G.317, V.318, H.319, R.343, G.346, G.347, V.348, D.358
- Ligands: MG.12
16 PLIP interactions:16 interactions with chain F- Hydrogen bonds: F:R.153, F:R.259, F:R.315, F:G.317, F:H.319, F:G.346, F:V.348
- Salt bridges: F:R.153, F:R.153, F:R.155, F:R.315, F:R.315, F:R.343, F:R.343
- pi-Cation interactions: F:R.153, F:H.319
ADP.13: 19 residues within 4Å:- Chain G: S.151, S.152, R.153, R.155, H.214, L.216, W.251, R.259, M.263, R.315, G.317, V.318, H.319, R.343, G.346, G.347, V.348, D.358
- Ligands: MG.14
16 PLIP interactions:16 interactions with chain G- Hydrogen bonds: G:R.153, G:R.259, G:R.315, G:G.317, G:H.319, G:G.346, G:V.348
- Salt bridges: G:R.153, G:R.153, G:R.155, G:R.315, G:R.315, G:R.343, G:R.343
- pi-Cation interactions: G:R.153, G:H.319
ADP.15: 19 residues within 4Å:- Chain H: S.151, S.152, R.153, R.155, H.214, L.216, W.251, R.259, M.263, R.315, G.317, V.318, H.319, R.343, G.346, G.347, V.348, D.358
- Ligands: MG.16
16 PLIP interactions:16 interactions with chain H- Hydrogen bonds: H:R.153, H:R.259, H:R.315, H:G.317, H:H.319, H:G.346, H:V.348
- Salt bridges: H:R.153, H:R.153, H:R.155, H:R.315, H:R.315, H:R.343, H:R.343
- pi-Cation interactions: H:R.153, H:H.319
- 8 x MG: MAGNESIUM ION(Non-functional Binders)
MG.2: 2 residues within 4Å:- Chain A: R.259
- Ligands: ADP.1
No protein-ligand interaction detected (PLIP)MG.4: 2 residues within 4Å:- Chain B: R.259
- Ligands: ADP.3
No protein-ligand interaction detected (PLIP)MG.6: 2 residues within 4Å:- Chain C: R.259
- Ligands: ADP.5
No protein-ligand interaction detected (PLIP)MG.8: 1 residues within 4Å:- Ligands: ADP.7
No protein-ligand interaction detected (PLIP)MG.10: 1 residues within 4Å:- Ligands: ADP.9
No protein-ligand interaction detected (PLIP)MG.12: 1 residues within 4Å:- Ligands: ADP.11
No protein-ligand interaction detected (PLIP)MG.14: 1 residues within 4Å:- Ligands: ADP.13
No protein-ligand interaction detected (PLIP)MG.16: 1 residues within 4Å:- Ligands: ADP.15
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Demir, M. et al., Structural basis for substrate binding, catalysis and inhibition of cancer target mitochondrial creatine kinase by a covalent inhibitor. Structure (2025)
- Release Date
- 2025-02-12
- Peptides
- Creatine kinase U-type, mitochondrial: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 8 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 8 x MG: MAGNESIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Demir, M. et al., Structural basis for substrate binding, catalysis and inhibition of cancer target mitochondrial creatine kinase by a covalent inhibitor. Structure (2025)
- Release Date
- 2025-02-12
- Peptides
- Creatine kinase U-type, mitochondrial: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H